Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ABBOTT LABORATORIES ABT

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.


NYSE:ABT - Post by User

Post by edwardebreen15on Jul 21, 2022 8:22am
68 Views
Post# 34839749

Catheters Market Size, Share, Demand and Growth 2022-2027

Catheters Market Size, Share, Demand and Growth 2022-2027

According to IMARC Group’s latest report, titled “Catheters Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global catheters market reached a value of US$ 18.9 Billion in 2021. A catheter stands for a thin tube inserted into a patient's body for therapeutic and diagnostic applications. It is manufactured with medical-grade materials, such as plastic, latex, silicone rubbers, polyvinyl chloride (PVC), etc. Catheters are used to deliver drugs into the body, besides monitoring and managing drainage of bodily fluids like urine, during surgery and post-operative recovery. As a result, they find extensive applications in treating different urological, neurovascular, and cardiovascular disorders.

 

Request for a PDF sample of this report: https://www.imarcgroup.com/catheters-market/requestsample

 

The growing prevalence of urological disorders, particularly among the geriatric population, is primarily driving the catheters market. Moreover, the rising preferences for minimally invasive surgeries (MI) and inflating medical expenditure capacities of consumers are also positively influencing the market growth. Furthermore, catheters are being increasingly utilized at healthcare centers for electrophysiological procedures involving the insertion of wire electrodes to measure cardiac electrical activity. Additionally, the emergence of robot-assisted surgical interventions is also augmenting the product demand. Besides this, the growing popularity of silver ion-coated, anti-microbial variants to minimize the incidences of catheter-associated infections and thrombosis is anticipated to further propel the market growth over the forecast period. Looking forward, IMARC Group expects the catheters market to reach US$ 31.3 Billion by 2027, exhibiting a CAGR of 8.67% during 2022-2027.

 

Checkout Now: https://www.imarcgroup.com/checkout?id=3648&method=1

 

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

 

Competitive Landscape with Key Players:

  • Abbott Laboratories
  • Braun Melsungen AG
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Corporation
  • ConvaTec Group PLC
  • Edwards Lifesciences Corporation
  • Hollister Incorporated
  • Johnson & Johnson
  • Medtronic plc
  • Stryker Corporation
  • Teleflex Incorporated.

Market Segmentation:

 

Breakup by Product Type:

  • Cardiovascular Catheters
  • Urology Catheters
  • Intravenous Catheters
  • Neurovascular Catheters
  • Specialty Catheters
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/catheters-market

 

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 

Related Reports by IMARC Group:

Cell Analysis Market: https://www.imarcgroup.com/cell-analysis-market

Organic and Natural Pet Food Market: https://www.imarcgroup.com/organic-natural-pet-food-market

Angioplasty Balloons Market: https://www.imarcgroup.com/angioplasty-balloons-market

Minimally Invasive Surgery Market: https://www.imarcgroup.com/minimally-invasive-surgery-market

Dental Implants Market: https://www.imarcgroup.com/dental-implants-market

 

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

 

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

<< Previous
Bullboard Posts
Next >>